PORTENT advances promising Point of Care technologies through:

Technology Development | Human Validation | User and Developer Training and Rotations | Commercialization

PORTENT translates breakthrough point-of-care diagnostics into rapid, affordable tests that reduce the burden of chronic disease, curb infectious threats, and strengthen prevention efforts across the United States. By integrating technology development with clinical validation, training, and lab-to-market programs, PORTENT accelerates earlier detection of conditions – from diabetes, heart disease to emerging infections – so providers can intervene sooner, patients stay healthier, and health care costs decline.

The Center is enabled by a one-of-a-kind international network of clinical, training, and device development facilities and unique worldwide expertise in Point of Care diagnostics, their application and commercialization. To enable the validation of technologies on a global range of populations and with a unique set of users, the Center has integrated core clinical and validation facilities across four continents:

North America (United States)  |  Africa (Uganda)  |  South America (Ecuador)  |  Asia (India)